Compare VLOS & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VLOS | AVIR |
|---|---|---|
| Founded | 2024 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 388.1M | 429.1M |
| IPO Year | 2024 | 2020 |
| Metric | VLOS | AVIR |
|---|---|---|
| Price | $10.72 | $5.10 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $9.42 |
| AVG Volume (30 Days) | 60.2K | ★ 245.7K |
| Earning Date | 08-13-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $351,367,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.55 | $2.81 |
| 52 Week High | $10.90 | $6.45 |
| Indicator | VLOS | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 48.40 | 46.26 |
| Support Level | N/A | $5.01 |
| Resistance Level | $10.73 | $5.76 |
| Average True Range (ATR) | 0.03 | 0.19 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 52.94 | 25.19 |
Velos Acquisition I Corp, formerly M3-Brigade Acquisition V Corp, is a blank check company.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.